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recurrence and metastasis and high in mortality. Lots of studies indicate that early cancer diagnosis can
effectively increase the survival rate of patients. But early stage cancer is difficult to be detected because
of its inconspicuous features. Hence, convenient and effective cancer detection methods are urgently
needed. In this paper, we propose to utilize deep autoencoder to learn latent representation of highdimensional mass spectrometry data. Meanwhile, as a contrast, traditional particle swarm optimization
(PSO) optimization algorithm are also used to select optimized features from mass spectrometry data.
The learned features are further evaluated on three cancer datasets. The experimental results
demonstrate that the cancer detection accuracy by learned features is as high as 100%. As our main
contribution, the deep autoencoder method used in this study is a feasible and powerful instrument for
mass spectrometry feature learning and also cancer diagnosis.
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ABSTRACT Cancer is still one of the most life threatening disease and by far it is still difficult to prevent,
prone to recurrence and metastasis and high in mortality. Lots of studies indicate that early cancer diagnosis
can effectively increase the survival rate of patients. But early stage cancer is difficult to be detected because
of its inconspicuous features. Hence, convenient and effective cancer detection methods are urgently needed.
In this paper, we propose to utilize deep autoencoder to learn latent representation of high-dimensional mass
spectrometry data. Meanwhile, as a contrast, traditional particle swarm optimization (PSO) optimization
algorithm are also used to select optimized features from mass spectrometry data. The learned features are
further evaluated on three cancer datasets. The experimental results demonstrate that the cancer detection
accuracy by learned features is as high as 100%. As our main contribution, the deep autoencoder method
used in this study is a feasible and powerful instrument for mass spectrometry feature learning and also
cancer diagnosis.
INDEX TERMS Early cancer diagnosis, deep autoencoder, particle swarm optimization, mass spectrometry
feature learning.

I. INTRODUCTION

Cancer is one of the most serious threats to human life
and health in today’s society, and it not only imposes death
threats and heavy psychological burdens on patients, but
also imposes a heavy financial burden on families and societies with very high treatment costs. According to the recent
confirmed global cancer statistics report from American
Cancer Society (ACS), nearly two million cancer patients
were diagnosed in 2018 around the world [1]. An important
reason for the low cure rate of cancer is that it is often
diagnosed too late. For example, the five years’ survival rate
of breast cancer is more than 95% in the first stage, while
it reduces to no more than 20% in the fourth stage. That is
to say, early detection is crucial for higher survival rate for a
The associate editor coordinating the review of this manuscript and
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cancer patient. Therefore, early diagnosis and treatment of
cancer has become a key means of cancer prevention and
treatment. Currently, the diagnosis of cancer depends mainly
on imaging diagnosis [2]–[5] and pathological diagnosis [6].
The diagnosis of cancer is mainly conducted by doctors to
examine for abnormal areas in the medical images, which
costs a lot of energy and is prone to misdiagnosis. On the other
hand, some cancers have no obvious symptoms in the medical
images in the early stage. In this case, non-invasive and efficient early screening becomes an important research topic.
Myomics and proteomics are the key research directions in
the field of bioinformatics in recent years [7]. Some studies
show that, when the body’s health condition changes, some
protein levels in the body will also change, which will result
in differences in metabolic substances. These differences can
be reflected in the measurement parameters of body fluids,
such as blood and saliva, which can be detected by mass
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spectrometry technology. Nowadays, biomass spectrometry technology has been widely used in proteomics and
metabolomics. It can be used in the sequence analysis of
amino acids in proteins, protein identification and quantitative analysis and disease diagnosis [8], [9]. Cancer biomarkers are substances produced directly by tumor cells or induced
by tumor cells. The detection of cancer biomarkers can
judge or predict the presence, pathogenesis and prognosis
of the cancer. However, mass spectrometry technology is
still not widely used in clinical diagnosis. One reason is the
difficulty in collecting and processing relevant mass spectrometry data. Another reason is due to the high dimensional
characteristics of mass spectrometry data [10], which makes
the detection model prone to over-fitting . In order to detect
cancer via the high-dimensional mass spectrometry data,
in this paper, we utilize deep autoencoder and particle swarm
optimization (PSO) algorithms to learn latent representation
of high-dimensional mass spectrometry data, so as to reduce
the dimension of mass spectrometry data for cancer detection. We evaluate the learned features by training and testing
different machine learning models for cancer detection task.
A. CONTRIBUTIONS

In this paper, we make four main research contributions:
1) A new phemotocytoma and paraganglioma (PPGL)
mass spectrometry dataset including 150 health samples
and 131 cancer samples are collected for cancer detection experiments.
2) The characteristics of two ovarian cancer datasets and
PPGL dataset are analyzed by principal component
analysis (PCA) method.
3) Autoencoder and PSO based feature learning and
selection methods are designed in this paper, and
1000 features are selected for cancer detection.
4) Cancer detection experiments are conducted based on
learned features and traditional machine learning models, and the results are compared between autoencoder
and PSO methods.
The above contributions can be represented by similar
mass spectrometry based cancer detection studies, which are
important for early screening and treatment of cancers.
B. ORGANIZATION

The rest of the paper is organised as follows. In section II,
related work in mass spectrometry based cancer detection is
presented. The datasets and preprocessing methods are introduced in section III. Then, the autoencoder and PSO based
feature learning methods for cancer detection are presented
in section IV. Section V depicts the experimental results
and analysis. We address the conclusions and future work in
section VI.
II. RELATED WORK

Mass spectrometry technology is being applied into cancer
detection, and there have been many convincing studies.
VOLUME 8, 2020

Early in 2003, Stattin and Hakama combined a protein mass spectrometry based method and artificial intelligence (AI) algorithms to distinguish non-cancer groups,
so as to determine better biomarkers [11]. In 2004,
Yang et al. proposed the metabonomics technology based on
high performance liquid chromatography (HPLC) [12]. They
distinguished liver cancer patients and healthy volunteers
by analyzing their urine samples. This method has better
specificity and sensitivity. Then, Semmes et al. discussed
the application of proteomic mass spectrometry technologies
in prostate cancer diagnosis [13]. Later, Kojima et al. successfully utilized mass spectrometry data to detect stomach
cancer [14]. De Petris et al. used SELDI-TOF-MS technology
to detect the S100A6 in tumor cell lysate in 39 patients, which
was very important for lung cancer cure test [15].
Recently, Liu et al. [16] proposed to detect tumor antigens from the ovarian cancer cell by proteomic-based methods. Their study indicated that the positive rate of serum
HSP70 autoantibody in patients with ovarian cancer was
21.7%, which could be used to discriminate cancer patients.
Jabbar et al. tried to detect pancreatic cancer by targeted
mass spectrometry technology, and they achieved a best accuracy of 97% [17]. Liu et al. [18] developed a pipeline for
biomarker development based on mass spectrometry technology, and their results showed a high predictive value with
sensitivity of 95%.
Generally, when the body’s organs become of lesions or
cancerous, the metabolites in the body change with the
body’s lesions. After years of development, mass spectrometry technology has been more mature. Now the mass
spectrometry technology is regarded as the most promising
technology for cancer diagnosis. In the diagnosis of tumor,
to find the features, which can best represent the characteristics of the tumor, is the focus of metabolic histology
research. On the other hand, machine learning models can
represent complex nonlinear mapping relationships and are
widely used to find the inherent rules of data. In this paper,
the deep autoencoder (DAE) and PSO algorithms are applied
into the feature learning of high-dimensional cancer mass
spectrometry data. Then, machine learning models are used
to classify the mass spectrometry data based on selected features. Experiments show that the autoencoder and PSO algorithms can learn the features that contribute to classification
well. Also, it indicates that mass spectrometry technology
combined with machine learning method is feasible and has
certain advantages for cancer detection.
III. DATASET

The datasets used in this paper include two ovarian cancer datasets, denoted as OC_4302 and OC_8702, and one
PPGL dataset. We select one health sample and one cancer sample from these three datasets separately, and their
heatmaps containing health samples and cancer samples are
plotted in Fig. 1. We can see that ovarian cancer datasets
have more obvious intensity contrast than PPGL datasets.
However, it is difficult to distinguish health and cancer
45157
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FIGURE 1. The heatmaps of mass spectrometry datasets.

samples by the intensity contrast of figures. Next, we will
introduce the preprocessing and the initial feature screening
methods.
A. OVARIAN CANCER DATASETS

The ovarian cancer datasets were acquired from the America Clinical Proteomics Program Database [19], which aim
to develop and apply proteomics technology. In this paper,
we will test on the ovarian cancer 4-3-02 dataset (OC_4302)
and the ovarian cancer 8-7-02 dataset (OC_8702). The
OC_4302 is a dataset with low-resolution collected using
a WCX2 chip. It contains 100 ovarian cancer samples and
100 health samples, and every sample has 15,154 features.
Baseline correction was manually carried out on these samples. The OC_8702 is also a dataset with low-resolution,
which contains 162 cancer samples and 100 normal samples
with 15,154 features. This dataset is curated with machine,
and it is quite different from the OC_4302 dataset.
B. PPGL DATASET

PPGL is a glandular nerve chain tumor that can be classified
as phemotocytoma and paraganglioma, depending on where
it occurs. The PPGL dataset used in this paper is collected
from a hospital in Shanghai city of China.
We firstly collected blood samples from PPGL patients
and healthy people who were not diagnosed with PPGL.
Then, the serum samples were processed and analyzed by
matrix-assisted laser analysis of ionizing flight time mass
spectrometry (MALDI-TOF-MS), and the mass spectrometry
data of these samples was consequently obtained. The PPGL
dataset includes 150 healthy samples and 131 PPGL samples,
each data has 104,960 original features. The mass spectrometry data is composed of the mass-to-charge ratio (m/z)
in horizontal coordinate and the intensity in the ordinated
45158

FIGURE 2. The original samples, baseline calibration samples and
normalization samples of mass spectrometry data.

coordinate. By analyzing mass spectrometry data, we can find
features containing classification information, so as to detect
and identify cancer.
VOLUME 8, 2020
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FIGURE 3. The mass spectrometry sampels by using first three principle components of three datasets.

C. MASS SPECTROMETRY PREPROCESSING

In this paper, the OC_4302 dataset is preprocessed based on
baseline calibration and normalization method, which is actually using the area under the curve (AUC) method. In order to
conveniently preprocess the data, we set the intensity values
to range of 0 and 10.
The original mass spectrometry samples of OC_4302 and
OC_8702 are shown in Fig. 2(a), which includes cancer samples and normal samples. The baseline calibrated mass spectrometry signals are shown in Fig. 2(b). Fig. 2(c) shows the
signals after normalization ([0,10]). PPGL mass spectrometry
data is exported by compassXport software, and the data is
organized with mzXML format. Unlike the ovarian cancer
dataset, PPGL data is metabolic mass spectrometry data. The
mass-to-charge ratio ranges between 60 and 1,000, and the
number of features is 104,960. The intensity values of massto-charge ratio between 60 and 100 are useless for cancer
diagnose. Hence, we actually eliminate data between this
range. And the number of features reduces to 95,022. Similarly, the preprocessed results of PPGL are shown in Fig. 2(d),
Fig. 2(e) and Fig. 2(f). We can see that the baseline wandering
problem is well relieved after baseline calibration and normalization for both ovarian cancer and PPGL data.
After preprocessing, we need to carry out initial feature
screening to reduce the number of features.
D. INITIAL FEATURE SCREENING

χ2 =

X (A − T )2

(1)
T
Generally, mass spectrometry has the characteristics of
high dimension but very small number of samples. Therefore,
we need to screen the mass spectrometry data. In this paper,
the single variable chi-square test (χ 2 test) is used to screen
the mass spectrometry data. The initial feature number of
ovarian cancer samples is 15,154, and the initial number of
features of PPGL samples is 104,960. We firstly calculate the
χ 2 values of these features by Eq. (1). In which A denotes the
observation value and T denotes the expected value. Then,
these features are sorted by these values. Finally, we select
VOLUME 8, 2020

FIGURE 4. The cumulative information of different number of features.

9000 features for ovarian cancer samples, and 100,000 features for PPGL samples after the initial screening in the first
stage.
E. FEATURES ANALYSIS

Generally, mass spectrometry data has significantly larger
features than samples, which makes it relatively difficult to
collect large enough samples through experiments. On the
contrast, numerous features are prone to train a model with
the risk of over-fitting. Therefore, we need to reduce the number of features of mass spectrometry data before using it for
cancer detection [20]. Based on PCA method, we plot the first
three principle components extracted from samples of three
datasets, and these samples with only three principle components are visualized in Fig. 3. We can see that all three datasets
tend to be divided into two categories, in which black dots
represent cancer samples and red dots represent healthy samples. However, OC_8702 dataset and PPGL dataset can be
obviously separated, whereas OC_4302 dataset has unclear
classification boundary.
45159
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global optimization algorithm, which is developed based on
concept of swarm intelligence [21]. It has been widely used in
many fields, such as neural network optimization, time series
analysis and feature selection [22].
According to the analysis earlier, we can find that
1000 features can express 100% information. Hence,
we select 1000 features to further test cancer detection models. We first select different features from the initial screening features randomly to generate 30 particle populations,
and each population contains 1000 feature indexes of subset
features. Then we use 70% samples extracted based on these
subset features in these populations to train linear classifiers,
and the classification accuracy is set as the objective function,
which are used to select the global optimal features in this
round. Next, these populations are updated, which means
the feature indexes are updated. The classifiers are trained
again to update the global optimal features in the next round.
We repeat this optimization process 20 times to complete
the feature selection. At last, these selected features can be
used to detect cancer, and we test on the remaining 30%
samples to test the classification results by these selected
features.

B. DEEP AUTOENCODER BASED FEATURE LEARNING
METHOD

FIGURE 5. The flowchart of PSO based feature learning method.

Next, we calculate the cumulative information of different
number of features, and the results are shown in Fig. 4.
We can see that OC_8702 dataset needs minimum number
of features to express 95% information, and PPGL dataset
needs maximum number of features to express 95% information. Although mass spectrometry data has a high dimension,
we can obtain more than 100% cumulative information with
1000 features for all three datasets. Therefore, in the next step,
we will try to learn 1000 features to represent these samples
for cancer detection.
IV. FEATURE LEARNING METHODS

In this section, we will introduce the PSO method and two
types of deep autoencoder models for mass spectrometry
feature learning.
A. PSO BASED FEATURE LEARNING METHOD

Firstly, we design a PSO algorithm to select features from
initial features, and the flowchart is shown in Fig. 5. PSO is a
45160

The deep autoencoder model is a commonly used deep learning method for feature learning. The autoencoder model is
shown in Fig. 6. In this paper, five layers are designed to learn
features from original mass spectrum features based on deep
autoencoder, which are denoted as L1, L2, L3, L4 and L5.
The input vector and the output vector of the autoencoder are
both the mass spectrum data after preprocessing. Therefore,
the input dimension of OC_4302 dataset is 9,000, and the
input dimension of OC_8702 dataset is 100,000. Herein, two
types of autoencoder are designed for feature learning. First
type is the deep autoencoder model with fully-connected (FC)
neuron nodes, denoted as DAE, and another type is deep
convolutional autoencoder (DCAE). The parameter setting
of these two types models are shown in Table 1. For both
OC_4302 and OC_8702 datasets, the DAE models are both
designed with 2000 × 1000 × 1000 structure. For ovarian
cancer dataset, DCAE model consists of 3 convolutional
layers, one max-pooling layer and one upsampling layer. The
number of convolutional kernels is set as 16, 1 and 1, and the
kernel sizes are set as 5, 3 and 1. The stride of convolution
operation is set as 1, and the pooling size is set as 9. On the
whole, ReLU function is selected as the activation function.
For PPGL dataset, DCAE model also consists of 3 convolutional layers, one max-pooling layer and one upsampling
layer. However, the stride of first convolution layer is set
as 10, and the pooling size is set as 10, due to the high
dimension of PPGL dataset. Furthermore, according to these
model structures, the middle L3 layer has just 1000 nodes,
corresponding to 1000 learned features, which can be easily
used for cancer classification.
VOLUME 8, 2020
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FIGURE 6. The feature learning method based on deep autoencoder.
TABLE 1. The architectural of deep autoencoders.

V. EXPERIMENTS AND ANALYSIS

In this section, we first show and analyze the learned features
of these samples based on PSO and autoencoder, followed
with the setting of the parameters of machine learning classification models, including extreme learning machine (ELM),
BPNN, support vector machine (SVM), k nearest neighbors
(KNN) and random forest (RF). At last, the cancer detection
results by learned features are illustrated and compared.
A. FEATURE LEARNING RESULTS

We conducted experiments to train feature learning models
for three datasets. For each dataset, we select one healthy
VOLUME 8, 2020

sample and one cancer sample to show the features as Fig. 7,
Fig. 8 and Fig. 9. The original features, 1000 features learned
by PSO, DAE, DCAE are shown in sub-figures, the blue
curves represent the features of healthy samples, and the
red curves represent the features of cancer samples. For
ovarian cancer datasets, we can see that the original features and learned features are distributed in the whole data
for both healthy samples and cancer samples. For PPGL
dataset, the original features and features learned by DCAE
are mainly distributed in the front. The differences in these
features may reflect the differences in the expression of some
proteins between healthy people and cancer patients, and
45161
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FIGURE 7. Learned features of one health sample (blue) and one cancer sample (red) of OC_4302 dataset.

FIGURE 8. Learned features of one health sample (blue) and one cancer sample (red) of OC_8702 dataset.

further exploration of these features may provide some basis
for the diagnosis of cancer.
Further, we can observe that these features learned by PSO
and DAE are different from the original features, and we cannot observe obvious characteristics of these features. We can
also find that features learned by DCAE have similar trends
for OC_8702 and PPGL datasets. Meanwhile, these features has opposite trend characteristics for OC_4302 dataset.
It indicates that DCAE can better learn the features of the
original data. We will further conduct cancer classification
experiments based on these features.
B. MEASURE METRICS AND MODEL PARAMETERS

In our experiments, we use three metrics, including Accuracy,
Sensitivity and Specificity, to evaluate the performances of
cancer detection. These three metrics are frequently used
in classification problems, which are based on four basic
metrics including TP (true positive), TN (true negative),
45162

FP (false positive) and FN (false negative). For classification problems, the Accuracy metric is often used to evaluate
classifiers, which represents the percentage of correct identification. As a quite intuitive metric, Accuracy does not fully
reveal the ability of the classification models, especially when
the samples are not balanced. Sensitivity and Specificity are
also two important evaluation metrics in disease diagnosis
studies, especially in cancer detection. Sensitivity (Recall)
can be used to describe the proportion of detected cancer
samples to the whole cancer samples. Therefore, a high
Sensitivity denotes a low probability of missed diagnosis.
Specificity can be used to describe the proportion of healthy
samples to the whole health samples. It indicates the ability
for detecting healthy people. Generally, a high Specificity
means a low probability of false diagnosis.
We obtained 1,000 features for classification by training
feature learning models based on PSO and autoencoder.
Then, samples based on these 1,000 features from three
VOLUME 8, 2020
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FIGURE 9. Learned features of one health sample (blue) and one cancer sample (red) of PPGL dataset.

FIGURE 10. Experimental results: (a-c) average classification results of ELM, BPNN, SVM, KNN and RF; (d-f) the classification result distribution of ELM,
BPNN, SVM, KNN and RF; (g-i) the distribution of three metrics.

datasets are generated to train classifiers, including ELM,
BPNN, SVM, KNN and RF. In our experiments, these classifiers are tested to get better model parameters. For these
models, the input dimension is equal to the number of original
mass spectrometry or 1,000. For ELM model, it is based on
FC neural network with one hidden layer. We use grid method
to search appropriate number of hidden nodes, which is set
as 5,000 finally. And the activation function is set as ReLu
function, which is equal to function max(0, x) and proved to
be effective for our experiments. ELM is a random model,
and its forecast results are fluctuating. Therefore, we conduct
five experiments and take the average result as the final
results of ELM. For BPNN, it is designed with one hidden
layers with 20 hidden nodes after many experiments. For the
VOLUME 8, 2020

SVM model, the kernel type is selected as the radial basis
function (RBF). For KNN, we set the parameter k (number
of neighbors) to 15, due to the small number of samples. For
RF, there are no important parameter to set.

C. CANCER DETECTION RESULTS

In this subsection, we will compare the classification results
between original, PSO and deep autoencoder features. After
training these classifiers with 70% samples, 30% samples are
used for test, and the detection results are shown in Fig. 10,
Fig. 11 and Table 2.
We can see that ELM and SVM achieved better average
classification results than BPNN, KNN and RF from Fig. 10
45163
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FIGURE 11. Experimental results: (a-c): average classification results based on three datasets; (d-f): average classification results based on different
feature learning methods.

TABLE 2. Experimental results: classification results by learned features.

(a-c), and SVM has abnormal Accuracy and Specificity in
10 (d-f). We can also observe from 10 (g-i) that the overall Accuracy, Sensitivity and Specificity are close to 100%.
45164

Meanwhile, we can see from Table 2 that ELM outperforms
other classifiers for ovarian cancer datasets, and SVM also
achieves best classification results for OC_8702 dataset based
VOLUME 8, 2020
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on features learned by DCAE. For PPGL dataset, ELM cannot
be trained based on original data, due to its high dimension, which is one reason for feature learning. RF, BPNN,
SVM (RF), and ELM (BPNN, SVM, KNN) achieved best
results for original features, PSO features, DAE features
and DCAE features. In fact, on the whole, the differences
between Sensitivity and Specificity of ELM and SVM are
smaller than other classifiers. It indicates that ELM and SVM
can predict with both low probability of missed diagnosis
and low probability of error diagnosis. Hence, ELM and
SVM are more suitable for mass spectrometry based cancer
detection.
From Fig. 11 (a-c), we can see that PPGL dataset
can be classified with highest Accuracy and Specificity,
while OC_8702 dataset has a little advantage in Sensitivity.
OC_4302 dataset performs worst for three metrics in three
datasets. From Table 2 we can see that we achieved better
classification results on OC_8702 dataset and PPGL dataset
than that on OC_4302 dataset, which is consistent with our
previous analysis for these dataset in Section III.
From Fig. 11 (d-f) we can see that classification results
based on DAE features are similar to results based on original
features. Results on DAE features are even a little worse
than results of original features from Table 2, because of the
fewer features than before. However, results based on PSO
features and DCAE features are better than results of original
features. It indicates that PSO and DCAE can satisfactorily
learn the feature representation and remove the effects of
noise.
From Table 2, we can also see that PSO features improve
the classification performance on OC_8702 and PPGL
dataset. While the classification results based on DCAE features are improved on both three datasets. Therefore, DCAE
model can be well applied in mass spectrometry feature learning for cancer detection, and the highest Sensitivity for three
datasets reach 96.55%, 100% and 100% based on learned
features.
VI. CONCLUSION

Medical data collected from sensor network is often used for
disease diagnosis [23], [24]. Mass spectrometry analysis are
important research directions in the field of bioinformatics
in recent years, especial for medical data. In this paper,
we designed machine learning models to diagnose cancer
based on the features learned from mass spectrometry data.
PSO and deep autoencoder are utilized to learn the representation features of mass spectrometry data for cancer detection.
Meanwhile, five machine learning models including ELM,
BPNN, SVM, KNN and RF are utilized to detect cancer
based on learned mass spectrometry features. Results show
that DCAE model is more suitable for high-dimension feature learning than traditional PSO method, and ELM and
SVM model can be well utilized to detect cancers. In future,
we will focus on the model optimization, and more mass
spectrometry data should be collected to improve and verify
the classification models.
VOLUME 8, 2020
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